Market Overview

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

5.500 0 (0%)

Data as of Oct 18, 2018

Prev. Close 5.5
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio 0
Shares Outstanding
Market Cap

Trade CVSI stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

The Most Actively Traded Over-The-Counter Stocks In September Spencer IsraelTue, 09 Oct 2018 13:06:50 -0400
CV Sciences Achieves Industry's First Hemp Extract GRAS Self-Affirmation Charles GrossTue, 11 Sep 2018 04:27:21 -0400
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week Javier HasseFri, 31 Aug 2018 16:08:16 -0400
45 Stocks Moving In Thursday's Mid-Day Session Lisa LevinThu, 30 Aug 2018 12:44:10 -0400
UPDATE: CV Sciences Said, '...nothing has fundamentally changed in our business. We continue to deliver solid financial results, and we remain very confident in our prospects.' luke@benzinga.comThu, 30 Aug 2018 10:16:07 -0400
OTC Cannabis-Related Stock CV Sciences Up 25% Thurs.; Co. Earlier Issued Press Release Highlighting 'we are keenly aware of recent market activity and certain disinformation disseminated by persons holding short positions in our stock' luke@benzinga.comThu, 30 Aug 2018 10:15:12 -0400
'Citron covering $CVSI short. Making 70% in a week is always a good trade. Stay tuned for more cannabis trades, our team is working hard to bring you the next 70% return.'-Citron Research Tweets Benzinga_NewsdeskWed, 29 Aug 2018 13:03:21 -0400
Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Aug. 21, 2018 luke@benzinga.comTue, 21 Aug 2018 17:14:19 -0400
Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Aug. 21, 2018 luke@benzinga.comTue, 21 Aug 2018 09:32:14 -0400
'$CVSI misrepresentation by management. The total bull case is based on REJECTED patents the company has never disclosed and continues to hype. Securities Fraud? Another IRTH special' -Citron Research Tweets Benzinga NewsdeskMon, 20 Aug 2018 13:23:29 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LogMeIn, Pinduoduo, Nevro, and CV Sciences and Encourages Investors to Contact the Firm Globe Newswire1 day ago
CV Sciences, Inc. Partners with the Rodale Institute on Organic and Industrial Hemp Research, Joining Patagonia and Dr. Bronner's Globe Newswire1 day ago
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In CV Sciences, Inc. (Other OTC: CVSI) To Contact The Firm Globe Newswire2 days ago
CV Sciences, Inc. to be a Featured Panelist at TheStreet's Investing Event on October 13th in New York, NY Globe Newswire6 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CV Sciences, Lannett, and Ampio and Encourages Investors to Contact the Firm Globe NewswireOct 10, 2018
Legal Cannabis Growing Market With Still a Mountain of Potential PRNewswireOct 10, 2018
CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CV Sciences, Inc. To Contact The Firm Business WireOct 09, 2018
CV Sciences, Inc.'s PlusCBD Oil™ featured on Oct. 3rd Episode of 'The Dr. Oz Show' Globe NewswireOct 09, 2018
CV SCIENCES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in CV Sciences, Inc. to Contact the Firm Business WireOct 04, 2018
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nevro, CV Sciences, and Lannett and Encourages Investors to Contact the Firm Globe NewswireOct 03, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Investors selling pot stocks "on the news" Seeking Alpha23 hours ago
Canada legalizes marijuana nationwide Seeking Alpha1 day ago
Pot stocks set for another up day Seeking Alpha1 day ago
Canopy Growth takeover of hemp researcher ebbut stokes pot stocks Seeking Alpha2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ... GuruFocus5 days ago
Medical cannabis OK'd in UK effective November 1 Seeking Alpha5 days ago
CV Sciences, Inc. to be a Featured Panelist at TheStreet's Investing Event on October ... GuruFocus6 days ago
Canopy Growth CEO talks cannabis demand Seeking Alpha6 days ago
Marijuana Stocks: 1,000% Gainers From My Seeking Alpha Portfolio - A Fun Back-Test Seeking AlphaOct 08, 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ... GuruFocusOct 05, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Company Profile

Read More

Visit company website

Brokerage Center

Compare All Online Brokerages